Edwards Lifesciences (EW): Analysts Lower PT After 3Q Preliminary Sales
Atleast two brokerages have lowered their price targets on Edwards Lifesciences Corp. (NYSE:EW) after the company slashed its third-quarter sales outlook, citing lower-than-expected transcatheter heart valve sales. On Tuesday, shares plunged nearly 20 percent in early trade following the preannouncement. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here